PTAB challenges

Proceedings overview

A single AIA trial proceeding, IPR2025-01392, has been filed against US patent 10327511. This proceeding resulted in a discretionary denial of institution, meaning the claims were not reviewed on their merits by the Patent Trial and Appeal Board (PTAB). This outcome indicates that the patent has survived an IPR challenge, and its claims remain intact, lending a degree of hardening to the patent's defensive posture.

IPR2025-01392 — TOP GLORY TRADING GROUP INC. et al. v. Cole Haan LLC

• Type: Inter Partes Review
• Filed: 2025-09-03
• Status: Discretionary Denial. This means the USPTO Director exercised discretion to deny institution of the IPR, so the merits of the patentability challenge were not examined by the PTAB.
• Judge panel: Following a policy change effective October 20, 2025, institution decisions, especially discretionary denials, were made personally by the USPTO Director, John Squires, after consultation with at least three PTAB Administrative Patent Judges (APJs). Given the filing date in September 2025, this decision likely fell under this new centralized review process.
• Petition grounds: Specific details regarding the challenged claims, prior art cited, and statutory bases (§ 102 / § 103) are not publicly available. This aligns with the USPTO's policy during this period to issue routine discretionary denial decisions as summary notices without detailed written explanations.
• Institution decision: The petition was denied institution, with the status last modified on 2026-02-10. The denial was discretionary, meaning the Director chose not to proceed with the trial based on policy factors rather than the merits of the invalidity arguments. Common reasons for discretionary denials at this time included considerations of parallel litigation (Fintiv factors), "settled expectations" (patent age and patent owner's activities), or efficiency. However, the specific reasoning for this particular case is not public.
• Final Written Decision (if issued): No Final Written Decision was issued because the IPR was not instituted.
• Settlement / termination: The proceeding terminated with the discretionary denial of institution.
• Appeal: Discretionary denials of institution are generally not appealable to the Federal Circuit.
• Defensive value: The claims of US10327511 were not adjudicated on their merits for patentability. Therefore, all claims remain valid and enforceable from this proceeding's perspective. For a defendant, this means that the specific arguments raised in this IPR petition were not successful in getting a trial started, making a future IPR based on substantially the same grounds by the same petitioner or a privy more challenging to institute.

Strategic summary

Currently, all claims of US10327511 are considered SUSTAINED / UNTESTED in the context of AIA trial proceedings, as the single IPR filed (IPR2025-01392) was denied institution without reaching a merits-based decision. This means the patent has not been narrowed or weakened by PTAB findings of unpatentability.

The estoppel landscape is relatively clear. Since no claims were found unpatentable, statutory estoppel under 35 U.S.C. § 315(e)(2) (which applies to grounds raised or that reasonably could have been raised) does not directly prevent a future petitioner from challenging the patent. However, the discretionary denial itself may carry preclusive effects or at least strong precedential weight for the same petitioner or their privies if they were to file a new petition challenging the same claims on the same grounds. The PTAB often considers the history of prior challenges in discretionary institution decisions, especially concerning issues like serial petitions or "settled expectations".

The single IPR against this patent, resulting in a discretionary denial, aligns with the trend observed in late 2025 where the USPTO Director exercised greater control over institution decisions, often issuing summary denials without detailed reasoning. This pattern signals a more challenging environment for petitioners seeking to institute IPRs, particularly when patents have been in force for some time or if there are parallel district court litigations. The involvement of Unified Patents in some other IPRs (though not explicitly stated for this one) indicates a defensive aggregator may be active in the broader patent landscape, but not directly on this patent for this IPR.

Recommended next steps

Given that IPR2025-01392 resulted in a discretionary denial of institution and no claims of US10327511 were invalidated:

• There is no Final Written Decision to link or quote from, as the IPR was not instituted on the merits.
• No active PTAB proceedings are currently pending for this patent.
• For a defendant facing assertion of this patent, the claims have not been formally challenged and found unpatentable by the PTAB. Therefore, any defensive strategy would need to consider alternative invalidity arguments, potentially through district court litigation, or explore new and distinct prior art grounds for a future IPR petition. It would be crucial to analyze the specific reasons typically cited for discretionary denials during late 2025, such as parallel litigation or "settled expectations," to assess the viability of any new IPR filing by the same entity or its privies.